Incannex (ASX: IHL) partners with Procaps to develop cannabis medicine for clinical trial on sleep apnea
Cannabis Law Report
OCTOBER 26, 2021
Incannex Healthcare Limited (ASX: IHL) has engaged pharmaceutical manufacturing company Procaps S.A The agreement between the two companies will see Procaps making IHL-42X for Incannex’s Phase 2, Phase 3, and open-label clinical trials. According to an article from the Lancet, sleep apnea affects 936 million adults globally.
Let's personalize your content